Kisspeptin-10 dose range

The amounts people commonly use, from the low end to the high end, with syringe units, schedule and half-life. The 8 published studies are one click away.

Small human studies Reproductive axis Also called Metastin 45-54

Common use ranges

From user guides and clinic write-ups. No drug label exists, and no study has tested these amounts in people. Very few sources. No drug label and no tested shot amount. The only shot amounts are user reports. Human studies gave it into a vein, which does not convert to a shot.

Sources disagree, or there are very few. The amounts below come from a small number of guides, and they do not line up well. Treat every number on this page as uncertain, and check each source yourself.

Half-life
about 4 minutes
How it is taken
subcutaneous injection
How long people use it
Not stated by the sources.
Mixing used for the units
5 mg vial + 2 mL water. 1 unit on a U-100 insulin syringe = 25 mcg.
Total amount per day, by tier
Starting100 mcg / dayHigher200 mcg / day
TierEach doseSyringe units5 mg vial + 2 mL waterHow oftenScheduleVial lastsat this tier
Starting [1]100 mcg4 units 0.04 mLonce a day100 mcg, daily or only when needed6+ weeks
Higher [2]200 mcg8 units 0.08 mLonce a day200 mcg, daily or only when neededabout 4 weeks

Good to know

  • The kisspeptin used in fertility trials under the skin was kisspeptin-54, a longer form.

Sources for these amounts

  1. Starting: Outliyr, kisspeptin-10 report
  2. Higher: Outliyr, kisspeptin-10 report

Half-life: Jayasena et al 2011, J Clin Endocrinol Metab

This page shows what labels, clinics and users report, and what studies gave. It is not medical advice and not a recommendation for anyone. Many of these compounds are not approved for human use. Check your own medicines and lab work with a licensed clinician before using anything.

See the science: 8 published studies

Amounts given to people in studies

Lowest0.01 mcg/kg IV
Most used0.3 mcg/kg IV
Highest12.5 mcg/kg per hour IV for 24 hours

How it was given: Into a vein (IV)

Short lab studies, 3 to 11 people per group.

Every study used for this page

Proof grade: Small human studies. Only small or uncontrolled human studies. Amounts are quoted as each study reported them. Where the abstract does not state an amount, the row says so.

StudyWho was studiedAmount given, as reportedRouteHow oftenHow longWhat the authors reported
PMID 216328072011Human, healthy men (bolus n = 6 at the 1 mcg/kg level, infusions n = 4 per arm)Bolus 0.01-3.0 mcg/kg. Infusion 1.5 mcg/kg/h and 4 mcg/kg/hIV bolus and IV infusionSingle bolus. Continuous infusionInfusion up to 22.5 hMaximal LH response at 1 mcg/kg bolus. 3 mcg/kg gave a smaller response. 1.5 mcg/kg/h raised LH pulse frequency 0.7 to 1.0/h
PMID 219767242011Human, healthy men and women (n = 4-5 per group)Men: IV bolus LH response at doses as low as 0.3 nmol/kg, FSH as low as 1.0 nmol/kg. Women follicular: maximal 10 nmol/kg IV bolus, 32 nmol/kg SC bolus, 720 pmol/kg/min IV infusion. Women preovulatory: 10 nmol/kg IV bolusIV bolus, SC bolus, IV infusionSingleAcuteMen and preovulatory women responded. Follicular-phase women did not respond to any route
PMID 229563462012Human, women: early follicular (n = 10), post-menopausal (n = 6), on contraceptives (n = 8)0.3 mcg/kgIVSingleSampled for 60 min afterLH rose in follicular, post-menopausal and progestogen groups, not combined pill. FSH rose only post-menopause
PMID 231532702013Human, men with type 2 diabetes (n = 5, infusion in 4) and healthy men (n = 7)Bolus 0.3 mcg/kg. Infusion 4 mcg/kg/hIV bolus and IV infusionSingle bolus. Infusion for 11 h, 5 days later11 h infusionLH rose (3.9 to 20.7 IU/l) and testosterone 8.5 to 11.4 nmol/l in hypogonadal diabetic men
PMID 260893022015Human, healthy men (n = 5 per dose group)0.1, 0.3 and 1.0 nmol/kg/h (also given for kisspeptin-54 and GnRH)IV infusionOne 3-h infusion per study visit, visits at least a week apart3 hKisspeptin-10 and -54 gave similar LH and FSH. GnRH about 3-fold higher than kisspeptin-10
PMID 425498272026Human, healthy men (study 1 n = 7, study 2 n = 4, study 3 n = 7, plus 12 controls)Acute 1.25-10.0 nmol/kg/h. Continuous 180 nmol/h for 5 days. Daily 8-h infusion at 150 nmol/h for 12 days. Bolus 1 nmol/kg after 12 daysSC infusionContinuous x 5 days, or 8 h on and 16 h off5 days or 12 daysAcute infusion dose-dependent. 5-day continuous: gonadotropins back to vehicle. Daily 8-h infusions kept LH up for 12 days
PMID 422304852026Human, healthy men (n = 3)12.5 mcg/kg/hIV infusionContinuous24 hLH rose 5- to 8-fold, peaked at 12-20 h, then fell 13-47% by end of infusion
PMID 300463072018Human, boys in Tanner stages I-V and adult men (n = 5 per group)Not stated in the abstractIV bolusSingleSampled 30 min before, 120 min afterLH/testosterone response absent in early puberty, present from Tanner stage V

How to read the study numbers

  • One study, one group. Each figure is what one team chose for its own participants or animals.
  • Route matters. An amount given into a vein (IV) is not the same as the same amount under the skin, in the nose or by mouth.
  • Animals are not small people. An animal amount is shown as the study gave it. It is not a human amount.
  • Short studies. Many studies ran days or weeks. They do not show what happens over longer use.

Common questions

What amounts of Kisspeptin-10 were used in human studies?

In the studies listed here, people were given from 0.01 mcg/kg IV up to 12.5 mcg/kg per hour IV for 24 hours. The amount used most often was 0.3 mcg/kg IV. These are what study teams chose for their participants under supervision.

Where do these Kisspeptin-10 numbers come from?

From 8 published studies, each linked to its PubMed or ClinicalTrials.gov record. Every figure was checked against the study abstract or its open full text. Proof grade: Small human studies.

How long does Kisspeptin-10 stay in the body?

Its half-life is about 4 minutes in people. Half-life is how long it takes for half of a dose to leave the blood. The effect can last longer than that.

Is this a recommendation for how much Kisspeptin-10 to use?

No. This page shows the amounts reported by drug labels, clinics and users, next to what researchers gave in studies. It is not medical advice and not a recommendation for anyone. Talk to a licensed clinician before using any of it.

See all peptides